8RPB
Structure of S79 Fab in complex with IgV domain of human PD-L1
Summary for 8RPB
Entry DOI | 10.2210/pdb8rpb/pdb |
Descriptor | heavy chain of S79 fab, light chain of S79 fab, Programmed cell death 1 ligand 1, ... (7 entities in total) |
Functional Keywords | immune system, fab |
Biological source | Homo sapiens More |
Total number of polymer chains | 3 |
Total formula weight | 61617.03 |
Authors | Svensson, A.,Kelpsas, V.,Laursen, M.,Rose, N. (deposition date: 2024-01-15, release date: 2024-06-19, Last modification date: 2024-10-16) |
Primary citation | Malinge, P.,Chauchet, X.,Bourguignon, J.,Bosson, N.,Calloud, S.,Bautzova, T.,Borlet, M.,Laursen, M.,Kelpsas, V.,Rose, N.,Gueneau, F.,Ravn, U.,Magistrelli, G.,Fischer, N. Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1. Mabs, 16:2362432-2362432, 2024 Cited by PubMed Abstract: In contrast to natural antibodies that rely mainly on the heavy chain to establish contacts with their cognate antigen, we have developed a bispecific antibody format in which the light chain (LC) drives antigen binding and specificity. To better understand epitope-paratope interactions in this context, we determined the X-ray crystallographic structures of an antigen binding fragment (Fab) in complex with human CD47 and another Fab in complex with human PD-L1. These Fabs contain a κ-LC and a λ-LC, respectively, which are paired with an identical heavy chain (HC). The structural analysis of these complexes revealed the dominant contribution of the LCs to antigen binding, but also that the common HC provides some contacts in both CD47 and PD-L1 Fab complexes. The anti-CD47 Fab was affinity optimized by diversifying complementary-determining regions of the LC followed by phage display selections. Using homology modeling, the contributions of the amino acid modification to the affinity increase were analyzed. Our results demonstrate that, despite a less prominent role in natural antibodies, the LC can mediate high affinity binding to different antigens and neutralize their biological function. Importantly, Fabs containing a common variable heavy (VH) domain enable the generation of bispecific antibodies retaining a truly native structure, maximizing their therapeutic potential. PubMed: 38849989DOI: 10.1080/19420862.2024.2362432 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.794 Å) |
Structure validation
Download full validation report